A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits
about
Combination of miglitol, an anti-diabetic drug, and nicorandil markedly reduces myocardial infarct size through opening the mitochondrial K(ATP) channels in rabbitsRole of protein kinase C in the reduction of infarct size by N-methyl-1-deoxynojirimycin, an alpha-1,6-glucosidase inhibitorGlycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.Antidiabetic drug miglitol inhibits myocardial apoptosis involving decreased hydroxyl radical production and Bax expression in an ischaemia/reperfusion rabbit heart.Both stimulation of GLP-1 receptors and inhibition of glycogenolysis additively contribute to a protective effect of oral miglitol against ischaemia-reperfusion injury in rabbits.Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemiaThe impact of current and novel anti-diabetic therapies on cardiovascular risk.MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy.Postconditioning effect of granulocyte colony-stimulating factor is mediated through activation of risk pathway and opening of the mitochondrial KATP channels.Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor.The anti-diabetic drug miglitol is protective against anginal ischaemia through a mechanism independent of regional myocardial blood flow in the dog.Salidroside attenuates myocardial ischemia-reperfusion injury via PI3K/Akt signaling pathway.
P2860
Q28345454-A2C780F0-32DD-4765-8181-CEC3F1F8B783Q28367858-872AAEB2-DD37-4F90-9A21-0B6AF7F5EC30Q32066328-78F82523-CE78-46E5-91D0-E85D55D4D2E9Q35047390-802282C8-FF4B-4EC5-A436-D3204DF79CAEQ35210037-50792CF9-048A-49E4-AB62-DEC80C2E2473Q36952365-71D12A8B-E39A-447B-865C-902B54E017DBQ38062033-19CE758B-76B3-415A-8D26-D761511B3A26Q38830597-BDB55618-6FF8-40F4-8996-38D25DF5D15AQ42943347-AD957C97-49B0-4B17-89B3-31E06E0CA86EQ44654251-CC400C43-627D-4DBE-9E4E-B5EACA916382Q46712835-2EEB4C6B-13E7-4033-A9AE-469E945E140BQ54448971-5A5561CD-26CC-470B-8F0D-C1F9442907B8
P2860
A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits
@en
type
label
A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits
@en
prefLabel
A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits
@en
P2093
P2860
P356
P1476
A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits
@en
P2093
G Takemura
H Fujiwara
K Hashimoto
M Kawasaki
S Minatoguchi
T Fujiwara
P2860
P304
P356
10.1038/SJ.BJP.0702970
P407
P577
1999-12-01T00:00:00Z